Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(9%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_3
1
9%
Ph phase_1
2
18%
Ph not_applicable
7
64%
Ph phase_2
1
9%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
2(18.2%)
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
7(63.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(7)
Terminated(1)
Other(2)

Detailed Status

Completed7
unknown2
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
87.5%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (18.2%)
Phase 21 (9.1%)
Phase 31 (9.1%)
N/A7 (63.6%)

Trials by Status

unknown218%
terminated19%
completed764%
recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
11